Plumbline develops different treatments customized to various animal species. This is thanks to our DNA plasmid-based platform technology.
We produce immunotherapies adapted for each animal species by using DNA platform technology.
Through our DNA platform technology, we strive to develop animal-specific therypies that treat a wide range of conditions such as cancer, anemia, and infectious virus diseases (foot-and-mouth disease)
These are related academic papers published to date.
The global veterinary pharmaceutical market was valued in $25.9 billion in 2015, and presented a steady annual growth of 5.7% over the past seven years.
How to Contact Us
You can share your opinion or inquire about our product pipeline.